Ticker > Company >

SMS Pharmaceuticals share price

SMS Pharmaceuticals Ltd.

NSE: SMSPHARMA BSE: 532815 SECTOR: Pharmaceuticals & Drugs  42k   68   9

240.50
-10.45 (-4.16%)
BSE: Today, 04:00 PM

Price Summary

Today's High

₹ 250.45

Today's Low

₹ 234

52 Week High

₹ 398

52 Week Low

₹ 114.2

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

2035.88 Cr.

Enterprise Value

2279.86 Cr.

No. of Shares

8.47 Cr.

P/E

34.69

P/B

3.41

Face Value

₹ 1

Div. Yield

0.17 %

Book Value (TTM)

₹  70.61

CASH

36.2 Cr.

DEBT

280.18 Cr.

Promoter Holding

64.67 %

EPS (TTM)

₹  6.93

Sales Growth

35.86%

ROE

9.53 %

ROCE

11.25%

Profit Growth

1110.03 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year35.86%
3 Year7.99%
5 Year8.81%

Profit Growth

1 Year1110.03%
3 Year-6.76%
5 Year3.58%

ROE%

1 Year9.53%
3 Year8.37%
5 Year9.94%

ROCE %

1 Year11.25%
3 Year9.06%
5 Year11.36%

Debt/Equity

0.517

Price to Cash Flow

40.62

Interest Cover Ratio

3.8112

CFO/PAT (5 Yr. Avg.)

1.15149041050822

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 64.67 19.40
Jun 2024 64.67 19.40
Mar 2024 64.67 19.40
Dec 2023 64.32 19.51
Sep 2023 64.32 10.71
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company’s PEG ratio is 0.0312544202800494.
  • The company has a good cash flow management; CFO/PAT stands at 1.15149041050822.

 Limitations

  • The company has shown a poor profit growth of -6.75561471401885% for the Past 3 years.
  • The company has shown a poor revenue growth of 7.99088098079244% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 166.64 161.48 245.8 164.45 196.75
Total Expenditure 138.82 132.6 212.31 130.99 164.89
Operating Profit 27.82 28.88 33.49 33.47 31.86
Other Income 0.81 1.49 1.65 1.37 1.31
Interest 5.57 5.95 5.61 4.67 4.61
Depreciation 7.9 8.01 7.92 8.38 8.62
Exceptional Items 0 0 0 0 0
Profit Before Tax 15.16 16.41 21.61 21.78 19.94
Tax 3.11 4.24 5.69 5.46 5.68
Profit After Tax 12.05 12.17 15.92 16.33 14.26
Adjusted EPS (Rs) 1.42 1.44 1.88 1.93 1.68

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 411.95 563.18 519.87 522.05 709.26
Total Expenditure 331.92 442.04 405.1 467.32 592.28
Operating Profit 80.02 121.14 114.77 54.74 116.98
Other Income 5.11 3.45 5.2 4.91 4.46
Interest 12.32 11.19 19.16 21.97 23.6
Depreciation 22.07 22.28 32.15 32.13 31.52
Exceptional Items 0 0 0 0 0
Profit Before Tax 50.76 91.12 68.65 5.55 66.33
Tax 18.07 30.16 0.62 1.47 16.91
Net Profit 32.69 60.96 68.04 4.08 49.42
Adjusted EPS (Rs.) 3.86 7.2 8.04 0.48 5.84

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 8.47 8.47 8.47 8.47 8.47
Total Reserves 358.96 419.76 485.3 486.63 562.02
Borrowings 68.22 147.41 149.5 121.13 122.09
Other N/C liabilities 46.25 58.85 43.23 43.04 43.96
Current liabilities 154.21 211.43 211.48 254.97 346.72
Total Liabilities 636.1 845.91 897.97 914.24 1083.25
Assets
Net Block 280.49 457.36 437.99 412.02 437.26
Capital WIP 42.12 6.74 11 33.19 30.27
Intangible WIP 0 0 0 0 0
Investments 45 45 45 45.1 45.1
Loans & Advances 38.47 9.1 9.32 10.7 19.04
Other N/C Assets 2.25 2.38 2.61 2.54 2.69
Current Assets 227.78 325.33 392.05 410.7 548.89
Total Assets 636.1 845.91 897.97 914.24 1083.25
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 50.76 91.12 68.65 5.55 66.33
Adjustment 28.66 27.76 49.7 52.79 53.74
Changes in Assets & Liabilities -27.6 -12.38 -58.38 -31.29 -54.55
Tax Paid -12.1 -16.05 -14.92 -4.6 -15.4
Operating Cash Flow 39.71 90.45 45.06 22.45 50.12
Investing Cash Flow -42.56 -151.59 -27.15 -29.76 -52.07
Financing Cash Flow -2.4 92.02 -11.75 -31.97 30.68
Net Cash Flow -5.25 30.88 6.16 -39.28 28.73

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 64.32 64.32 64.67 64.67 64.67
hima bindu potluri 17.47 17.47 17.73 17.73 17.73
potluri infra projects ll... 8.68 8.68 8.68 8.68 8.68
potluri laboratories priv... 1.32 1.32 1.32 1.32 1.32
ramesh babu potluri 18.49 18.49 18.49 18.49 18.49
trilok potluri 2.58 2.58 2.58 2.58 2.58
tvt infracon llp 0.02 0.02 0.12 0.12 0.12
vamsi krishna potluri 15.74 15.74 15.74 15.74 15.74
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 35.68 35.68 35.33 35.33 35.33
aniruddh mundra 1.13 1.13 1.13 1.13 1.13
investor education and pr... - 0.07 0.08 0.08 0.08
quant mutual fund - quant... - - - - 2.54
sudeepthi gopineedi 1.59 1.56 1.56 1.56 1.56
venkata praveen talluri 1.53 1.56 1.56 1.56 1.56
venkata subbaraju penmats... 2.13 2.13 2.13 2.13 2.13
vivek mundra 1.23 1.23 1.23 1.23 1.23
quant mutual fund - quant... - - 1.98 2.13 -
investor education and pr... 0.07 - - - -

Ratings & Research Reports

Company Presentations

Company News

SMS Pharmaceuticals - Quaterly Results 8 Nov, 6:57 PM SMS Pharmaceuticals - Quaterly Results 8 Nov, 6:57 PM SMS Pharmaceuticals informs about communication to shareholders 29 Aug, 4:27 PM SMS Pharmaceuticals - Quaterly Results 5 Aug, 3:23 PM SMS Pharmaceuticals - Quaterly Results 5 Aug, 3:23 PM SMS Pharmaceuticals - Quaterly Results 5 Aug, 3:23 PM SMS Pharmaceuticals informs about certificate 12 Jul, 10:14 AM SMS Pharmaceuticals - Quaterly Results 29 May, 1:33 PM SMS Pharmaceuticals informs about disclosures 21 Mar, 2:44 PM SMS Pharmaceuticals informs about disclosure 21 Mar, 10:52 AM SMS Pharmaceuticals - Quaterly Results 8 Feb, 7:04 PM SMS Pharmaceuticals - Quaterly Results 8 Feb, 7:04 PM SMS pharmaceuticals informs about closure of trading window 29 Dec, 12:03 PM SMS Pharmaceuticals informs about disclosure 22 Dec, 12:45 PM Sms Pharmaceuticals informs about disclosure 15 Dec, 4:54 PM Sms Pharmaceuticals informs about disclosure 15 Dec, 3:10 PM SMS Pharmaceuticals informs about disclosure 15 Dec, 2:22 PM SMS Pharmaceuticals informs about transcript of conference call 18 Nov, 3:06 PM SMS Pharmaceuticals informs about disclosure 16 Nov, 10:07 AM SMS Pharmaceuticals informs about disclosure 15 Nov, 2:20 PM SMS Pharmaceuticals informs about newspaper publication 9 Nov, 12:57 PM SMS Pharmaceuticals - Quaterly Results 8 Nov, 1:05 PM SMS Pharmaceuticals informs about newspaper advertisement 8 Sep, 1:10 PM SMS Pharmaceuticals informs about newspaper advertisement 4 Sep, 12:31 PM SMS Pharmaceuticals approves to pledge of equity shares of associate company 8 Aug, 4:24 PM SMS Pharmaceuticals - Quaterly Results 8 Aug, 1:49 PM SMS Pharmaceuticals - Quaterly Results 8 Aug, 1:49 PM SMS Pharmaceuticals - Quaterly Results 8 Aug, 1:49 PM Sms Pharmaceuticals informs about RTA certificate 11 Jul, 5:14 PM SMS Pharmaceuticals - Quaterly Results 24 May, 1:29 PM SMS Pharmaceuticals - Quaterly Results 24 May, 1:29 PM SMS Pharmaceuticals - Quaterly Results 24 May, 1:29 PM SMS Pharmaceuticals informs about conference call 23 May, 4:58 PM SMS Pharmaceuticals informs about disclosure 15 Mar, 12:52 PM SMS Pharmaceuticals informs about disclosure 15 Mar, 10:24 AM SMS Pharmaceuticals - Quaterly Results 9 Feb, 12:24 PM SMS Pharmaceuticals - Quaterly Results 9 Feb, 12:24 PM SMS Pharmaceuticals - Quaterly Results 9 Feb, 12:24 PM Sms Pharmaceuticals informs about conference call transcript 23 Nov, 12:26 PM SMS Pharmaceuticals - Quaterly Results 12 Nov, 11:32 AM SMS Pharmaceuticals - Quaterly Results 12 Nov, 11:32 AM SMS Pharmaceuticals acquires 4.9% stake in Provenio Astral International LLP 19 Oct, 12:27 PM SMS Pharmaceuticals informs about newspaper advertisement 26 Aug, 10:37 AM SMS Pharmaceuticals informs about newspaper advertisement 25 Aug, 12:23 PM SMS Pharmaceuticals informs about communication on TDS 25 Aug, 12:18 PM SMS Pharmaceuticals - Quaterly Results 13 Aug, 1:30 PM SMS Pharmaceuticals - Quaterly Results 13 Aug, 1:30 PM SMS Pharmaceuticals - Quaterly Results 13 Aug, 1:30 PM Sms Pharmaceuticals informs about conference call 11 Aug, 4:37 PM SMS Pharmaceuticals gets CEP approval for Ibuprofen 22 Jul, 6:03 PM

SMS Pharmaceuticals Stock Price Analysis and Quick Research Report. Is SMS Pharmaceuticals an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into SMS Pharmaceuticals and its performance over the period of time. SMS Pharmaceuticals stock price today is Rs 239.3.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. SMS Pharmaceuticals cash from the operating activity was Rs 50.1247 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. SMS Pharmaceuticals has a Debt to Equity ratio of 0.517 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In SMS Pharmaceuticals , the EPS growth was 1110.0725 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, SMS Pharmaceuticals has OPM of 16.493646789049 % which is a good sign for profitability.
     
  • ROE: SMS Pharmaceuticals have a poor ROE of 9.5322 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of SMS Pharmaceuticals is Rs 239.3. One can use valuation calculators of ticker to know if SMS Pharmaceuticals share price is undervalued or overvalued.
Last Updated on:
Brief about SMS Pharmaceuticals

SMS Pharmaceuticals Limited Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

SMS Pharmaceuticals Limited is a leading pharmaceutical company based in India. With a strong focus on manufacturing and supplying a wide range of active pharmaceutical ingredients (APIs), intermediates, and formulations, the company has established itself as a trusted player in the industry.

The company boasts a robust manufacturing infrastructure, including multiple state-of-the-art facilities that adhere to strict regulatory guidelines and quality standards. With a strong commitment to research and development, SMS Pharmaceuticals Limited continues to innovate and develop new products to meet the evolving needs of the pharmaceutical market.

SMS Pharmaceuticals Limited - Share Price

The share price of SMS Pharmaceuticals Limited reflects the market value of the company's stocks. Investors keen on long-term stock analysis can closely monitor the share price as an indicator of the company's performance and growth potential.

For a comprehensive analysis of the SMS Pharmaceuticals Limited share price, investors can utilize the pre-built screening tools available on our website. These tools provide valuable insights into various factors that may influence the share price, such as market trends, historical data, and peer comparison.

SMS Pharmaceuticals Limited - Balance Sheet

The balance sheet of SMS Pharmaceuticals Limited gives investors a snapshot of the company's financial position. It reveals information about the company's assets, liabilities, and shareholders' equity. By analyzing the balance sheet, investors can assess the company's financial health and stability.

To perform a detailed balance sheet analysis, investors can make use of our premium features. These features offer tools such as DCF Analysis, BVPS Analysis, Earnings Multiple Approach, and DuPont Analysis. These analytical tools provide a comprehensive understanding of the company's financial performance and help in the calculation of fair value.

SMS Pharmaceuticals Limited - Annual Report

The annual report of SMS Pharmaceuticals Limited is a valuable resource for investors seeking a comprehensive understanding of the company's operations and financial performance over a specific period. It provides a detailed analysis of the company's business strategies, market outlook, achievements, and future prospects.

On our website, investors can access and download the annual reports of SMS Pharmaceuticals Limited. These reports are a key source of information for long-term stock investors looking for in-depth stock analysis and insights into the company's performance.

SMS Pharmaceuticals Limited - Dividend

Dividend payment is an important consideration for long-term stock investors. SMS Pharmaceuticals Limited has a track record of consistent dividend payments, reflecting its financial stability and commitment to rewarding shareholders.

Investors can keep track of the company's dividend history and payout ratio to assess the potential returns on their investment. Our website provides up-to-date information on SMS Pharmaceuticals Limited's dividend payouts, ensuring that investors have access to the latest data.

SMS Pharmaceuticals Limited - Quarterly Result

The quarterly result of SMS Pharmaceuticals Limited provides investors with timely information on the company's financial performance and operational updates. By analyzing the quarterly results, investors can gauge the company's growth trajectory and its ability to meet set targets.

Investors can leverage our pre-built screening tools to access the quarterly results of SMS Pharmaceuticals Limited. These tools provide a comprehensive overview of the company's financial highlights without the inclusion of specific financial data points.

SMS Pharmaceuticals Limited - Stock Price Chart

The stock price chart of SMS Pharmaceuticals Limited presents a visual representation of the company's stock performance over a specific period. It helps investors identify trends, patterns, and potential buying or selling opportunities.

On our website, investors can find an interactive stock price chart for SMS Pharmaceuticals Limited, coupled with various technical indicators. These features enable investors to conduct a thorough analysis of the stock's price movements and make informed investment decisions.

SMS Pharmaceuticals Limited - News

Staying updated with the latest news is crucial for long-term stock investors. Our website provides a dedicated section for SMS Pharmaceuticals Limited news, where investors can access relevant information regarding the company's developments, collaborations, regulatory changes, and market updates.

By regularly checking the news section, investors can stay informed and make well-informed decisions based on the latest market trends and events affecting SMS Pharmaceuticals Limited.

SMS Pharmaceuticals Limited - Concall Transcripts

Concall transcripts play a significant role in understanding the company's business strategies, financial performance, and market outlook. They offer insights into the discussions and presentations made during the company's conference calls with analysts and investors.

On our website, investors can easily access and download the concall transcripts of SMS Pharmaceuticals Limited. These transcripts serve as an additional resource for long-term stock investors seeking a deeper understanding of the company's prospects and performance.

SMS Pharmaceuticals Limited - Investor Presentations

Investor presentations provide an overview of SMS Pharmaceuticals Limited's business overview, growth strategies, financial performance, and future outlook. These presentations are designed to give investors a comprehensive understanding of the company's operations and growth prospects.

At our website, investors can find downloadable investor presentations of SMS Pharmaceuticals Limited. These presentations are a valuable resource for those looking to analyze the company's potential and make well-informed investment decisions.

SMS Pharmaceuticals Limited - Promoters and Shareholders

Promoters and shareholders play a crucial role in the success and governance of SMS Pharmaceuticals Limited. Promoters are individuals or entities who have initiated the company, while shareholders are individuals or entities who hold shares in the company.

Our website provides detailed information about the promoters and major shareholders of SMS Pharmaceuticals Limited. Investors can gain insights into the company's ownership structure and the key individuals or entities driving its growth.

By considering the insights provided on our website and utilizing the pre-built screening tools and premium features, long-term stock investors can conduct a thorough stock analysis of SMS Pharmaceuticals Limited. We aim to empower our users with the necessary resources to make informed investment decisions based on accurate and reliable information.

Read More
X